Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Esperion Therapeutics Inc (NASDAQ: ESPR) closed at $1.54 in the last session, up 2.67% from day before closing price of $1.50. In other words, the price has increased by $2.67 from its previous closing price. On the day, 3.93 million shares were traded. ESPR stock price reached its highest trading level at $1.54 during the session, while it also had its lowest trading level at $1.48.
Ratios:
We take a closer look at ESPR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Warren Eric sold 239 shares for $1.87 per share. The transaction valued at 446 led to the insider holds 159,759 shares of the business.
Halladay Benjamin sold 11 shares of ESPR for $20 on Feb 19 ’25. The Chief Financial Officer now owns 240,671 shares after completing the transaction at $1.86 per share. On Feb 19 ’25, another insider, Warren Eric, who serves as the Officer of the company, bought 239 shares for $1.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 304687456 and an Enterprise Value of 751138304. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92. Its current Enterprise Value per Revenue stands at 2.26 whereas that against EBITDA is 13.791.
Stock Price History:
The Beta on a monthly basis for ESPR is 0.84, which has changed by -0.25961536 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.47. The 50-Day Moving Average of the stock is -18.43%, while the 200-Day Moving Average is calculated to be -27.92%.
Shares Statistics:
According to the various share statistics, ESPR traded on average about 4.36M shares per day over the past 3-months and 5337890 shares per day over the past 10 days. A total of 197.85M shares are outstanding, with a floating share count of 195.89M. Insiders hold about 0.99% of the company’s shares, while institutions hold 65.75% stake in the company. Shares short for ESPR as of 1740700800 were 29144177 with a Short Ratio of 6.69, compared to 1738281600 on 31243405. Therefore, it implies a Short% of Shares Outstanding of 29144177 and a Short% of Float of 14.770000999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
